Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Sonos Charts. Click Here for more Sonos Charts.](/p.php?pid=staticchart&s=N%5ESONO&p=8&t=15)
SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in
hand-carried ultrasound for point-of-care medicine, announced today the
introduction of SonoGT™ Global Targeted
technology, an advance that capitalizes on the power of the M-Turbo
platform to drive a new level of color flow imaging, wireless
connectivity and workflow integration for anesthesia, emergency
medicine, critical care and other acute point-of-care markets.
“SonoGT technology demonstrates the intrinsic
capabilities of the M-Turbo system architecture to address our global,
multiple point-of-care markets with targeted solutions,”
said Kevin M. Goodwin, SonoSite President and CEO. “This
advance is aimed at increasing imaging capabilities and clinical
productivity and includes a wide range of new technologies and options.”
The company plans to begin customer shipments of new M-Turbo systems
with SonoGT technology in the fourth quarter. Customers can separately
purchase SonoGT technology and upgrade existing M-Turbo systems via an
easy software download from a USB thumb drive. The new SonoGT technology
platform offers the following capabilities:
Color Performance
ColorHD™ Technology –
A proprietary, color Doppler algorithm that harnesses the power of the
M-Turbo system’s digital signal processor to
increase color performance, sensitivity and frame rates. Available on
all transducers, ColorHD technology works in parallel with multiple
M-Turbo algorithms, including SonoHD™ imaging
technology, to provide increased diagnostic information and better
visualization of color flow, particularly in low flow states. ColorHD
technology also comes with a variable sector size for the P10x/8-4 MHz
and the P21x/5-1 MHz phased array transducers for increased frame rates
during cardiac imaging.
Wireless Solutions
SonoRemote™ Control –
A new accessory enabled by the SonoGT technology platform untethers the
clinician from the ultrasound system during procedures to increase
ergonomic comfort and is expected to be very useful in sterile field
procedures. Based on Bluetooth® wireless
technology, the SonoRemote control can operate within a sterile bag or
sheath and can be used to adjust system controls from within a radius of
10 meters. SonoSite plans to begin shipping this option in the first
quarter of 2009.
SonoRoam™ Technology –
Using 802.11b/g technology, SonoRoam technology enables wireless image
transfer from the M-Turbo system to a PACS system via DICOM®
and to a personal computer via SonoSite’s
SiteLink™ so that clinicians can quickly
retrieve the information from any location. Wireless connectivity is
increasingly viewed as a critical component to reduce medical errors and
speed time to diagnosis in a portable ultrasound system.
Workflow Integration
DICOM Storage Commit and DICOM Modality Performed Procedure
Step have been added to the M-Turbo system to complete the IHE
profile (Integrating the Healthcare Enterprise) Scheduled Workflow (SWF)
Integration Profile. This facilitates seamless clinical integration of
ordering, scheduling, image acquisition, storage, viewing and billing of
patient procedures.
Patient Management – Patient
demographics can now be entered before, during or after the exam. This
allows flexibility in getting the procedure completed in time-critical
situations where documentation is secondary to that of the procedure
itself. DICOM Multi-Modality Worklist (MWL) queries can be made to the
hospital information network to gain quick access to patient scheduling
for ultrasound and non-ultrasound procedures.
New USB Bar Code Reader – This
accessory allows clinicians to quickly and accurately enter
patient information and update exam information prior to its entry into
the patient record. SonoSite’s bar code
reader now is powered through a USB port freeing AC power for another
device.
New Exam Types
Ophthalmic Exam – The L25x/13-6 MHz
transducer offers an ophthalmic exam setting for evaluation of globe
rupture, intraocular foreign bodies, and retinal detachment.
TCD and Orbital Exam – The P21x/5-1
MHz transducer is optimized for assessment of intracranial blood flow
and structures.
About SonoSite
SonoSite, Inc. (www.sonosite.com)
is the innovator and world leader in hand-carried ultrasound.
Headquartered near Seattle, the company is represented by ten
subsidiaries and a global distribution network in over 100 countries.
SonoSite’s small, lightweight systems are
expanding the use of ultrasound across the clinical spectrum by
cost-effectively bringing high performance ultrasound to the point of
patient care. The company employs over 600 people worldwide.
Bluetooth and DICOM are registered trademarks or trademarks of their
respective owners.